Cargando…
Enhanced sialylation and in vivo efficacy of recombinant human α-galactosidase through in vitro glycosylation
Human α-galactosidase A (GLA) has been used in enzyme replacement therapy for patients with Fabry disease. We expressed recombinant GLA from Chinese hamster ovary cells with very high productivity. When compared to an approved GLA (agalsidase beta), its size and charge were found to be smaller and m...
Autores principales: | Sohn, Youngsoo, Lee, Jung Mi, Park, Heung-Rok, Jung, Sung-Chul, Park, Tai Hyun, Oh, Doo-Byoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133871/ https://www.ncbi.nlm.nih.gov/pubmed/23527859 http://dx.doi.org/10.5483/BMBRep.2013.46.3.192 |
Ejemplares similares
-
Engineering of Sialylated Mucin-type O-Glycosylation in Plants
por: Castilho, Alexandra, et al.
Publicado: (2012) -
Enhancing the sialylation of recombinant EPO produced in CHO cells via the inhibition of glycosphingolipid biosynthesis
por: Kwak, Chan-Yeong, et al.
Publicado: (2017) -
Effect of the developmental stage and tissue position on the expression and glycosylation of recombinant glycoprotein GA733-FcK in transgenic plants
por: Lim, Chae-Yeon, et al.
Publicado: (2015) -
Increasing the α 2, 6 Sialylation of Glycoproteins May Contribute to Metastatic Spread and Therapeutic Resistance in Colorectal Cancer
por: Park, Jung-Jin, et al.
Publicado: (2013) -
New α-galactosidase-inhibiting aminohydroxycyclopentanes
por: Weber, Patrick, et al.
Publicado: (2021)